Announcements Trials
Browse Landscape

Phase

Phase 1 14Phase 2 6Phase NA 4Phase 3 3Phase 1/2 2Phase 4 1Phase 2/3 1

Status

Completed 3Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 44INDUSTRY 6NIH 1NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 1Other 1Head & Neck 1Genitourinary 1Dermatologic 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 1Mucositis 1Melanoma 1Head and Neck Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Carboplatin 273Paclitaxel 267Gemcitabine 244Bevacizumab 226Cisplatin 218pembrolizumab 214Docetaxel 210Pemetrexed 162Capecitabine 148Fluorouracil 129Oxaliplatin 121Cyclophosphamide 121Nivolumab 112Dexamethasone 100Trastuzumab 89Leucovorin 87Cetuximab 85Rituximab 83Irinotecan 82Injections 81Erlotinib Hydrochloride 70Prednisone 68Doxorubicin 68Temozolomide 67atezolizumab 65Bortezomib 65Ipilimumab 64Fulvestrant 59Radiotherapy 54Drug Therapy 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × INDUSTRY × Therapeutics × Clear all
NCT07406724 2026-02-12

HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma

Qingdao Sino-Cell Biomedicine Co., Ltd.

Phase 2 Not yet recruiting
90 enrolled
Dermatologic

Melanoma

NCT04046250 2023-08-25

TK112690

Tosk, Inc.

Phase 2 Completed
22 enrolled 10 charts
Head & NeckOther

Head and Neck Neoplasms, Mucositis

NCT00828854 2022-06-30

Study of the Effect of the Addition of SNDX-275 (Entinostat) to Continued Aromatase Inhibitor (AI) Therapy in Postmenopausal Women With ER+ Breast Cancer Whose Disease is Progressing

Syndax Pharmaceuticals

Phase 2 Completed
27 enrolled 13 charts
Breast

Breast Neoplasms

NCT01929200 2015-05-22

Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation

Betta Pharmaceuticals Co., Ltd.

Phase 2 Unknown
120 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00305929 2010-06-02

Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure

STEBA France

Phase 2 Completed
8 enrolled
Genitourinary

Prostatic Neoplasms

NCT00805636 2010-05-12

Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.

Aposense Ltd.

Phase 2 Unknown
30 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡